Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals
Anti-HDV-positive individuals are at high risk of adverse liver-related outcomes. The incidence of HCC was negligible among individuals without cirrhosis and among individuals with low baseline PAGE-B and/or Fibrosis-4 scores. Therefore, these scores can be used to guide HCC surveillance strategies and potentially also for treatment prioritization.
Authors
- R. Bart Takkenberg
- Krishna Mohan Agarwal (ORCID: https://orcid.org/0000-0002-8099-3369)
- Robert A. de Man (ORCID: https://orcid.org/0000-0002-1932-7412)
- Hans Blokzijl (ORCID: https://orcid.org/0000-0003-4240-7506)
- Lesley A. Patmore (ORCID: https://orcid.org/0000-0002-2911-2140)
- Ivana Carey (ORCID: https://orcid.org/0000-0001-5806-3731)
- Remco van Dijk (ORCID: https://orcid.org/0000-0002-5505-7122)
- Adriana J. J. Lammers
- Louis Jansen (ORCID: https://orcid.org/0000-0002-3371-7492)
- Dirk Posthouwer
- A. G. W. van Hulzen
- Milan J. Sonneveld (ORCID: https://orcid.org/0000-0002-9253-563X)
- Michelle Spaan (ORCID: https://orcid.org/0000-0002-6692-1553)
- Özgür M. Koc (ORCID: https://orcid.org/0000-0003-3678-5703)
- Mark A. A. Claassen (ORCID: https://orcid.org/0000-0002-8824-3722)
- Jurriën G.P. Reijnders
- Hanneke van Soest
- Harry L.A. Janssen
- Samantha Brouwer
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Erasmus MC (NL)
- Maastricht University (NL)
- Medisch Centrum Haaglanden (NL)
- OLVG (NL)
- Haga Hospital (NL)
- Isala (NL)
- Amsterdam University Medical Centers (NL)
- Rijnstate Hospital (NL)
- King's College Hospital (GB)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Clinical Gastroenterology and Hepatology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1016/j.cgh.2024.08.036
- Citations
- 3
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Gilead Sciences